Updates

Bajaj Healthcare received initial approval from the CDSCO's Subject Expert Committee to manufacture and market Cenobamate Tablets (a next-gen antiseizure medication). This makes BHL the first Indian company to secure this clearance, reinforcing its specialty pharma position.